Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/18/2025

Cardiac Conduction Disorders Management

Indications for Pacemaker Implantation

  • The American College of Cardiology recommends pacemaker implantation in patients who develop symptomatic bradycardia, frequent sinus pauses that produce symptoms, symptomatic chronotropic incompetence, or higher-degree AV block develops, which is a Class IIa indication 1, 2
  • Pacemaker implantation should be considered in patients with a PR interval >300 ms and symptoms, as recommended by the American College of Cardiology 1
  • First-degree AV block is defined as a prolongation of the PR interval beyond 0.20 seconds, with a PR interval >300 ms potentially causing hemodynamic compromise, according to the American Heart Association and American College of Cardiology 3, 2, 4, 1, 5

Diagnostic Evaluation

  • A transthoracic echocardiogram is recommended to exclude structural heart disease in patients with newly detected conduction disorders, especially LBBB, according to the American College of Cardiology 6
  • Repeat ambulatory monitoring is recommended if symptoms develop, such as syncope, presyncope, or dizziness, as advised by the American College of Cardiology 6
  • Periodic ECG follow-up is recommended for patients with first-degree AV block, with more frequent monitoring if coexisting bundle branch block is present, and consideration of ambulatory monitoring if symptoms suggest intermittent higher-degree block, as recommended by the American College of Cardiology and American Heart Association 3, 4, 1, 5
  • Exercise testing can be used to assess chronotropic response and PR interval shortening with activity in patients with mild symptoms and PR interval <300 ms, as suggested by the American College of Cardiology 7

Medical Management

  • Medications that further slow AV conduction, such as beta-blockers, calcium channel blockers, and digoxin, should be used with caution, as advised by the European Society of Cardiology 8
  • IV atropine may be used in patients with significant bradycardia and hypotension, as recommended by the European Society of Cardiology 8
  • Atropine should be avoided in patients who have undergone cardiac transplantation, as it may paradoxically worsen AV block, according to the American Heart Association 4

Special Considerations

  • Certain patient populations, such as those with neuromuscular diseases or history of progression to higher-degree block, may require additional monitoring and preparation for potential progression, as recommended by the American Heart Association and American College of Cardiology 9, 10, 1
  • Biventricular pacing rather than conventional right ventricular pacing should be considered for patients with first-degree AV block who require pacing due to symptoms or hemodynamic compromise and have left ventricular dysfunction, according to the American College of Cardiology 3
  • Standard monitoring is sufficient for isolated first-degree AV block in the perioperative setting, but atropine should be available if bradycardia develops, according to the American Society of Anesthesiologists 3, 2

Contraindications for Pacemaker Implantation

  • Permanent pacemaker implantation is not indicated for asymptomatic patients with sinus node dysfunction, first-degree AV block, and rare isolated PVCs and PACs, as recommended by the American College of Cardiology, American Heart Association, and Heart Rhythm Society 2

REFERENCES